RE:InMed Expands Bod Dr. Mansour was previously with Xenon Pharmaceuticals as its executive vice-president. He also held similar positions at Pfizer and Wyeth Pharmaceuticals, prior to founding Sabila Biosciences LLC, where he is currently the chief executive officer. Mr. Puil is currently a managing partner at a private equity fund based in California. Prior to that, he held senior positions at several firms including Bolder Investment Partners in Vancouver (now Haywood Securities), where he was a partner and portfolio manager; and in San Francisco at Gissen & Associates as portfolio manager, and the Encompass Fund as senior analyst. He currently serves as a board director of two Toronto Stock Exchange companies. He holds a degree in economics from the University of Victoria in British Columbia and is a chartered financial analyst charterholder.